Loading…
Azitra, Inc. is projected to rise to $0.137 by 2027, a +3% move from its current price of $0.1325. AZTR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.1263 | $0.1324 | $0.1387 | -0.11% |
| Aug 6 | $0.1238 | $0.1322 | $0.1412 | -0.21% |
| Aug 7 | $0.1218 | $0.1321 | $0.1432 | -0.32% |
| Aug 8 | $0.1202 | $0.1319 | $0.1448 | -0.43% |
| Aug 9 | $0.1187 | $0.1318 | $0.1463 | -0.54% |
| Aug 10 | $0.1174 | $0.1316 | $0.1476 | -0.64% |
| Aug 11 | $0.1162 | $0.1315 | $0.1488 | -0.75% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.1162 | $0.1315 | $0.1488 | -0.75% |
| Week 2 | $0.1096 | $0.1305 | $0.1554 | -1.49% |
| Week 3 | $0.1046 | $0.1295 | $0.1604 | -2.23% |
| Week 4 | $0.1005 | $0.1286 | $0.1646 | -2.97% |
| Week 5 | $0.0968 | $0.1276 | $0.1681 | -3.70% |
| Week 6 | $0.0936 | $0.1266 | $0.1713 | -4.42% |
| Week 7 | $0.0907 | $0.1257 | $0.1742 | -5.13% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Azitra, Inc. is an early-stage clinical biopharmaceutical company focused on precision dermatology, developing therapies using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S.
epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Phase 1b/2a clinical trial for treating Netherton syndrome, a skin disease; and ATR-01, a genetically modified strain of S. epidermidis that expresses an engineered recombinant human filaggrin protein, which is in the IND-enabling phase for treating ichthyosis vulgaris, a skin disease.
It has a joint development agreement with Bayer for the identification and characterization of S. epidermidis strains for topical formulations. Azitra, Inc. was incorporated in 2014 and is headquartered in Branford, Connecticut.
Azitra, Inc. trades at a current price of $0.1357 and has a market cap of $2.2M. Its rank is 5393. The stock’s near-term technical picture is mixed, with a neutral sentiment overall.
A major floor 55.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.9% below — buyers have tended to step in here.
The nearest ceiling, 73.6% above — a clean break opens room to run.
A major ceiling 106.8% above — clearing it would confirm fresh momentum.
Key AZTR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AZTR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.13 | Buy | $0.1309 | Buy |
| MA 10 | $0.1315 | Buy | $0.1323 | Buy |
| MA 20 | $0.1362 | Sell | $0.1407 | Sell |
| MA 50 | $0.1754 | Sell | $0.1663 | Sell |
| MA 100 | $0.1986 | Sell | $0.2129 | Sell |
| MA 200 | $0.2658 | Sell | $1.51 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.70 | Neutral |
| Stoch RSI (14) | 85.94 | Sell |
| CCI (20) | -28.40 | Neutral |
| Williams %R (14) | -65.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -1.48 | Sell |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 35.00 | Neutral |
| TRIX (15) | -1.38 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 52.65 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 0.13 | Buy |
| ADX (14) | 22.29 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day technical picture shows NEUTRAL sentiment, RSI14 40, SMA50 $0.1877, and SMA200 $0.29. Support is at $0.129 and resistance at $0.238.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.126 | $0.1325 | $0.1514 | 0% | Neutral | |
| $0.1023 | $0.137 | $0.1976 | +3% | Neutral | |
| $0.1194 | $0.1686 | $0.2577 | +27% | Bullish | |
| $0.1201 | $0.1771 | $0.2831 | +34% | Bullish | |
| $0.0991 | $0.1521 | $0.2523 | +15% | Neutral | |
| $0.092 | $0.1465 | $0.2509 | +11% | Neutral | |
| $0.094 | $0.1549 | $0.2729 | +17% | Neutral | |
| $0.0858 | $0.1461 | $0.264 | +10% | Neutral | |
| $0.1114 | $0.1959 | $0.3622 | +48% | Bullish | |
| $0.122 | $0.2214 | $0.4182 | +67% | Bullish | |
| $0.1272 | $0.2676 | $0.5518 | +102% | Bullish | |
| $0.1632 | $0.3626 | $0.834 | +174% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.126 | $0.1325 | $0.1633 | +0.00% |
| September 2026 | $0.1024 | $0.1236 | $0.155 | -6.74% |
| October 2026 | $0.0983 | $0.1201 | $0.1534 | -2.79% |
| November 2026 | $0.0993 | $0.1225 | $0.1587 | +1.99% |
| December 2026 | $0.0927 | $0.1154 | $0.1514 | -5.80% |
Click any year to see its month-by-month AZTR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Azitra, Inc.'s 2026 outlook centres on $0.1325, within a $0.126 to $0.1514 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, AZTR could reach as high as $0.1976, with a base case around $0.137 and support toward $0.1023 — roughly +3% from $0.1325. A consolidation phase looks the most probable path here.
Expect AZTR to range from $0.1194 to $0.2577 through 2028. The $0.1686 average target implies a +27% move from current prices. That is up +23% on the projected 2027 average. Momentum favours further upside here.
The AZTR price prediction for 2029 points to an average of $0.1771 (low $0.1201, high $0.2831) — a potential gain of +34% on today's $0.1325. Buyers look set to stay in control over this stretch.
In 2030, AZTR is projected to trade between $0.0991 and $0.2523, averaging $0.1521 — a potential gain of +15% from today's $0.1325. That is -14% versus the projected 2029 average. Price action looks broadly range-bound.
Azitra, Inc.'s 2031 outlook centres on $0.1465, within a $0.092 to $0.2509 range. That is -4% versus the projected 2030 average. That marks a +11% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, AZTR could reach as high as $0.2729, with a base case around $0.1549 and support toward $0.094 — roughly +17% from $0.1325. Price action looks broadly range-bound.
Expect AZTR to range from $0.0858 to $0.264 through 2033. The $0.1461 average target implies a +10% move from current prices. That is -6% versus the projected 2032 average. A consolidation phase looks the most probable path here.
The AZTR price prediction for 2034 points to an average of $0.1959 (low $0.1114, high $0.3622) — a potential gain of +48% on today's $0.1325. Momentum favours further upside here.
In 2035, AZTR is projected to trade between $0.122 and $0.4182, averaging $0.2214 — a potential gain of +67% from today's $0.1325. That is up +13% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Azitra, Inc.'s 2040 outlook centres on $0.2676, within a $0.1272 to $0.5518 range. That is up +21% on the projected 2035 average. That marks a +102% change versus current levels. Momentum favours further upside here.
By 2050, AZTR could reach as high as $0.834, with a base case around $0.3626 and support toward $0.1632 — roughly +174% from $0.1325. Buyers look set to stay in control over this stretch.
Investing $1,000 in AZTR today (≈ 7,547.169811 AZTR) could be worth
$2,736.61
+$1,736.61 (+174%) by 2050 · US Dollar
Based on the average projected AZTR price of $0.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AZTRwould be worth at today's price.
$1,000 invested in AZTR on Jul 31, 2025 (≈ 842.696417 AZTR) would be worth
$111.66
-$888.34 (-88.8%) today · 0.11× · US Dollar
Based on a AZTR entry price of $1.19 vs. today's $0.1325.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.126 | $1,051.59 | +5.2% |
| 1 month ago | $0.167 | $793.41 | -20.7% |
| 3 months ago | $0.247 | $536.44 | -46.4% |
| 6 months ago | $0.245 | $540.82 | -45.9% |
| 1 year ago | $1.19 | $111.66 | -88.8% |
| All time (3.1y) ago | $988 | $0.13 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AZTR forecast.
Our base-case forecast reaches $0.27 around 2050.
Implied market cap at $0.27: $4.37M
The year-by-year forecast shows gradual price movement with notable upside in later years. For 2026 the avg is $0.1357 and min/max are $0.129/$0.1454 with ROI 0. In 2027 the avg is $0.1471 (min $0.1069, max $0.2188) with ROI 8.4.
The 2028 forecast is more bullish, avg $0.182 (min $0.1245, max $0.2886) with ROI 34.1. The 2029 avg $0.1818 (min $0.118, max $0.3028) with ROI 34. The 2030 avg $0.1605 (min $0.0994, max $0.2783) with ROI 18.3.
Through 2034 the avg climbs to $0.2077 (min $0.1089, max $0.4053) with ROI 53.1, and 2035 shows avg $0.2342 (min $0.1181, max $0.4675) with ROI 72.6. The path extends to 2040 with avg $0.2879 (min $0.1296, max $0.6317) and ROI 112.2, and to 2050 with avg $0.3514 (min $0.1581, max $0.8083) and ROI 159. These forecasts show NEUTRAL sentiment in 2026–2033, turning BULLISH in 2034–2050.
While these figures illustrate potential upside, they are estimates, not guarantees.
Tap a question to reveal the answer.
2030 avg $0.1605 with min $0.0994 and max $0.2783; ROI 18.3%.
Forecasts show a mix of neutral near-term years and bullish longer-term years, with positive ROIs in multiple years (e.g., 2028 ROI 34.1%, 2029 ROI 34%, 2034 ROI 53.1%, 2035 ROI 72.6%, 2040 ROI 112.2%, 2050 ROI 159%). These are estimates and not guarantees.
The max values in the forecast exceed $0.50 in later years: 2040 max $0.6317 and 2050 max $0.8083, indicating potential to surpass $0.50 in those years.
Sentiment: NEUTRAL; RSI14: 40. SMA50: $0.1877; SMA200: $0.29. The 30-day range is $0.09 to $0.2045, with support at $0.129 and resistance at $0.238.
Current price is $0.1357 and market cap is $2.2M, with a rank of 5393.
Azitra, Inc. Community Discussion
0Share your Azitra, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.